Equity in access to cancer cachexia clinical trials 2022

PFIZER, S.A

Objecte

Topic: Cancer cachexia.

Destination: Projects that will be considered for Pfizer support will focus on supporting initiatives to improve identification and equity in access to cancer cachexia clinical trials. It is their intent to support quality improvement projects. It is not their intent to support clinical research projects. Projects evaluating the efficacy of therapeutic or diagnostic agents will not be considered.

Budget: $100,000.

Duration: Not indicated.

Are you interested in this call?

Estàs interessat?

Omple el següent formulari per rebre més informació: